Alignment Healthcare [ALHC] vs Elevance Health [ELV] Detailed Stock Comparison
Alignment Healthcare
NASDAQ
Loading...
Elevance Health
NYSE
Loading...
TLDR: Quick Comparison Summary
Based on 20 vital metrics comparison: Alignment Healthcare wins in 2 metrics, Elevance Health wins in 16 metrics, with 0 ties. Elevance Health appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Alignment Healthcare | Elevance Health | Better |
|---|---|---|---|
| P/E Ratio (TTM) | -24.81 | 14.86 | Alignment Healthcare |
| Price-to-Book Ratio | 23.34 | 1.80 | Elevance Health |
| Debt-to-Equity Ratio | 233.85 | 68.84 | Elevance Health |
| PEG Ratio | 0.15 | -0.68 | Elevance Health |
| EV/EBITDA | 396.28 | 7.85 | Elevance Health |
| Profit Margin (TTM) | -1.53% | 2.83% | Elevance Health |
| Operating Margin (TTM) | 2.30% | 5.29% | Elevance Health |
| EBITDA Margin (TTM) | 2.30% | 5.29% | Elevance Health |
| Return on Equity | -38.53% | 12.42% | Elevance Health |
| Return on Assets (TTM) | -1.50% | 4.65% | Elevance Health |
| Free Cash Flow (TTM) | $-6.65M | $4.55B | Elevance Health |
| Dividend Yield | N/A | 1.32% | N/A |
| 1-Year Return | 49.43% | -30.27% | Alignment Healthcare |
| Price-to-Sales Ratio (TTM) | 0.99 | 0.42 | Elevance Health |
| Enterprise Value | $3.12B | $74.45B | Elevance Health |
| EV/Revenue Ratio | 0.93 | 0.39 | Elevance Health |
| Gross Profit Margin (TTM) | 13.15% | N/A | N/A |
| Revenue per Share (TTM) | $17 | $829 | Elevance Health |
| Earnings per Share (Diluted) | $-0.27 | $23.58 | Elevance Health |
| Beta (Stock Volatility) | 1.18 | 0.59 | Elevance Health |
Performance
News Sentiment
Key Stats
Valuation
Financials
Short Interest
Dividends
Alignment Healthcare vs Elevance Health Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Alignment Healthcare | 2.95% | -1.95% | 5.49% | 30.21% | -3.98% | 48.01% |
| Elevance Health | -0.16% | 9.46% | 13.56% | 0.88% | -17.30% | -4.34% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Alignment Healthcare | 49.43% | 54.56% | -1.16% | -1.16% | -1.16% | -1.16% |
| Elevance Health | -30.27% | -25.67% | 17.88% | 137.97% | 505.64% | 375.59% |
News Based Sentiment: Alignment Healthcare vs Elevance Health
Alignment Healthcare
News based Sentiment: MIXED
Alignment Health reported impressive Q2 results and raised its full-year guidance, indicating strong growth and positive momentum. However, the stock price decline, significant insider selling, and mixed institutional activity create a more nuanced investment picture, making this a month of both positive developments and potential concerns.
Elevance Health
News based Sentiment: MIXED
Elevance Health is facing both positive and negative developments this month. While institutional investment and reaffirmed guidance are encouraging, the lawsuit, enrollment declines, and expected earnings decrease create uncertainty. The overall narrative suggests a company navigating challenges while maintaining a reasonably strong position.
Performance & Financial Health Analysis: Alignment Healthcare vs Elevance Health
| Metric | ALHC | ELV |
|---|---|---|
| Market Information | ||
| Market Cap | $3.41B | $78.92B |
| Market Cap Category | Mid cap | Large cap |
| 10 Day Avg. Volume | 3,324,710 | 1,900,110 |
| 90 Day Avg. Volume | 4,055,717 | 2,032,487 |
| Last Close | $17.11 | $349.94 |
| 52 Week Range | $10.11 - $21.06 | $273.71 - $510.24 |
| % from 52W High | -18.76% | -31.42% |
| All-Time High | $28.59 (May 03, 2021) | $567.26 (Sep 02, 2024) |
| % from All-Time High | -40.15% | -38.31% |
| Growth Metrics | ||
| Quarterly Revenue Growth | 0.49% | 0.14% |
| Quarterly Earnings Growth | 0.49% | -0.24% |
| Financial Health | ||
| Profit Margin (TTM) | -0.02% | 0.03% |
| Operating Margin (TTM) | 0.02% | 0.05% |
| Return on Equity (TTM) | -0.39% | 0.12% |
| Debt to Equity (MRQ) | 233.85 | 68.84 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | $0.71 | $194.46 |
| Cash per Share (MRQ) | $2.54 | $154.51 |
| Operating Cash Flow (TTM) | $63.23M | $6.45B |
| Levered Free Cash Flow (TTM) | $44.12M | $12.05B |
| Dividends | ||
| Last 12-Month Dividend Yield | N/A | 1.32% |
| Last 12-Month Dividend | N/A | $4.97 |
Valuation & Enterprise Metrics Analysis: Alignment Healthcare vs Elevance Health
| Metric | ALHC | ELV |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | -24.81 | 14.86 |
| Forward P/E | -32.59 | 10.03 |
| PEG Ratio | 0.15 | -0.68 |
| Price to Sales (TTM) | 0.99 | 0.42 |
| Price to Book (MRQ) | 23.34 | 1.80 |
| Market Capitalization | ||
| Market Capitalization | $3.41B | $78.92B |
| Enterprise Value | $3.12B | $74.45B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 0.93 | 0.39 |
| Enterprise to EBITDA | 396.28 | 7.85 |
| Risk & Other Metrics | ||
| Beta | 1.18 | 0.59 |
| Book Value per Share (MRQ) | $0.71 | $194.46 |
Financial Statements Comparison: Alignment Healthcare vs Elevance Health
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | ALHC | ELV |
|---|---|---|
| Revenue/Sales | $926.93M | $49.78B |
| Cost of Goods Sold | $820.90M | N/A |
| Gross Profit | $106.03M | N/A |
| Research & Development | N/A | N/A |
| Operating Income (EBIT) | $-5.39M | N/A |
| EBITDA | $2.24M | N/A |
| Pre-Tax Income | $-9.33M | $2.29B |
| Income Tax | $21,000 | $548.00M |
| Net Income (Profit) | $-9.35M | $1.74B |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | ALHC | ELV |
|---|---|---|
| Cash & Equivalents | $446.18M | $8.56B |
| Total Current Assets | $774.49M | N/A |
| Total Current Liabilities | $457.12M | N/A |
| Long-Term Debt | $329.50M | $28.18B |
| Total Shareholders Equity | $109.00M | $43.85B |
| Retained Earnings | $-1.02B | $35.55B |
| Property, Plant & Equipment | $7.75M | N/A |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | ALHC | ELV |
|---|---|---|
| Operating Cash Flow | $-38.58M | $1.77B |
| Capital Expenditures | $-8.25M | $-267.00M |
| Free Cash Flow | $8.36M | $1.79B |
| Debt Repayment | N/A | $110.00M |
| Common Stock Repurchase | N/A | $-378.00M |
Short Interest & Institutional Ownership Analysis
| Metric | ALHC | ELV |
|---|---|---|
| Shares Short | 12.85M | 3.68M |
| Short Ratio | 3.28 | 1.71 |
| Short % of Float | 0.10% | 0.02% |
| Average Daily Volume (10 Day) | 3,324,710 | 1,900,110 |
| Average Daily Volume (90 Day) | 4,055,717 | 2,032,487 |
| Shares Outstanding | 191.78M | 227.48M |
| Float Shares | 152.55M | 224.66M |
| % Held by Insiders | 0.04% | 0.00% |
| % Held by Institutions | 0.94% | 0.93% |
Dividend Analysis & Yield Comparison: Alignment Healthcare vs Elevance Health
| Metric | ALHC | ELV |
|---|---|---|
| Last 12-Month Dividend | N/A | $4.97 |
| Last 12-Month Dividend Yield | N/A | 1.32% |
| 3-Year Avg Annual Dividend | N/A | $5.08 |
| 3-Year Avg Dividend Yield | N/A | 0.32% |
| 3-Year Total Dividends | N/A | $15.23 |
| Ex-Dividend Date | N/A | Mar 10, 2025 |